🇺🇸 Antimicrobial agent in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Blood Creatinine Increased — 1 report (10%)
- Blood Urea Increased — 1 report (10%)
- Bronchopulmonary Aspergillosis — 1 report (10%)
- C-Reactive Protein Increased — 1 report (10%)
- Cardiac Failure — 1 report (10%)
- Coronary Artery Stenosis — 1 report (10%)
- Death — 1 report (10%)
- Drug Interaction — 1 report (10%)
- Gamma-Glutamyltransferase Increased — 1 report (10%)
- Haemoptysis — 1 report (10%)
Other Infectious Diseases approved in United States
Frequently asked questions
Is Antimicrobial agent approved in United States?
Antimicrobial agent does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antimicrobial agent in United States?
Universidad Miguel Hernandez de Elche is the originator. The local marketing authorisation holder may differ — check the official source linked above.